RACE to the future: Horizon Europe Teaming for Excellence Project

In 2023, the IIMCB initiated the “RNA and Cell Biology – from Fundamental Research to Therapies” project (acronym RACE). Our goal with this grant is to become a world-class Centre of Excellence in RNA and Cell Biology, combining scientific excellence with a strong emphasis on commercialization activities to effectively translate our research into market-ready therapies.

By 2029 we aim to reach a critical mass of 20 scientific groups with a complementary expertise in RNA and cell biology; train the next generation of world-class entrepreneurial researchers; develop sustainable core facilities tailored to industry needs; establish a professional technology transfer incubator; and, finally, digitalize our administrative processes. All activities to fulfill these objectives are on course and are implemented with the support of our project partners: The Medical Research Council Human Genetics Unit (MRC-HGU) at the University of Edinburgh, UK, and the Flanders Institute for Biotechnology (VIB), Belgium.

RACE is funded by a grant of nearly €15,000,000 from the Horizon Europe Teaming for Excellence program (GA No. 101059801) and was ranked first in the 2022 call. The project implementation period is from September 1, 2023, to August 30, 2029.

To learn more about the RACE project click here.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.